Author

Mathurin Fumery

EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY
EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY

Mathurin Fumery  et al.

COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS

EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY
EFFECTIVENESS AND SAFETY OF RISANKIZUMAB INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: A GETAID COHORT STUDY

PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF ADALIMUMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING ADALIMUMAB BIOSIMILAR SB5; BASELINE RESULTS
PERFUSE: A FRENCH NON-INTERVENTIONAL COHORT STUDY OF ADALIMUMAB-NAÏVE AND TRANSITIONED PATIENTS RECEIVING ADALIMUMAB BIOSIMILAR SB5; BASELINE RESULTS

Mathurin Fumery  et al.

IGA VASCULITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASES: A MULTICENTER STUDY OF THE GETAID AND GFEV
IGA VASCULITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASES: A MULTICENTER STUDY OF THE GETAID AND GFEV

Mathurin Fumery  et al.

WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY
WHICH SECOND-LINE BIOLOGIC AFTER ANTI-TNF FAILURE DURING CROHN'S DISEASE: USTEKINUMAB OR VEDOLIZUMAB, A MULTICENTRE RETROSPECTIVE STUDY

Mathurin Fumery  et al.

REAL-WORLD MULTICENTER COMPARISON OF SHORT AND LONG-TERM EFFECTIVENESS AND SAFETY BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT
REAL-WORLD MULTICENTER COMPARISON OF SHORT AND LONG-TERM EFFECTIVENESS AND SAFETY BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT

Mathurin Fumery  et al.

USTEKINUMAB IS MORE EFFECTIVE THAN AZATHIOPRINE TO PREVENT ENDOSCOPIC POSTOPERATIVE RECURRENCE IN CROHN´S DISEASE
USTEKINUMAB IS MORE EFFECTIVE THAN AZATHIOPRINE TO PREVENT ENDOSCOPIC POSTOPERATIVE RECURRENCE IN CROHN´S DISEASE

Mathurin Fumery  et al.

NO BENEFIT OF CONCOMITANT IMMUNOMODULATOR THERAPY ON EFFICACY OF NON - ANTI-TNF BIOLOGICS IN INFLAMMATORY BOWEL DISEASES: A META-ANALYSIS
NO BENEFIT OF CONCOMITANT IMMUNOMODULATOR THERAPY ON EFFICACY OF NON - ANTI-TNF BIOLOGICS IN INFLAMMATORY BOWEL DISEASES: A META-ANALYSIS

Mathurin Fumery  et al.

COMPLETE ENDOSCOPIC HEALING IS ASSOCIATED WITH LOWER DISABILITY THAN PARTIAL MUCOSAL HEALING IN CROHN’S DISEASE: A PROSPECTIVE MULTICENTRIC STUDY
COMPLETE ENDOSCOPIC HEALING IS ASSOCIATED WITH LOWER DISABILITY THAN PARTIAL MUCOSAL HEALING IN CROHN’S DISEASE: A PROSPECTIVE MULTICENTRIC STUDY

Mathurin Fumery  et al.

INCREASED INCIDENCE OF CANCER AND MORTALITY IN A PEDIATRIC-ONSET IBD POPULATION-BASED COHORT OF 1344 PATIENTS DIAGNOSED BETWEEN 1988 AND 2011: THE INSPIRED STUDY
INCREASED INCIDENCE OF CANCER AND MORTALITY IN A PEDIATRIC-ONSET IBD POPULATION-BASED COHORT OF 1344 PATIENTS DIAGNOSED BETWEEN 1988 AND 2011: THE INSPIRED STUDY

Mathurin Fumery  et al.

NEW THERAPEUTIC STRATEGIES HAVE CHANGED THE NATURAL HISTORY OF PAEDIATRIC INFLAMMATORY BOWEL DISEASES: RESULTS FROM A POPULATION-BASED COHORT OVER A 24-YEAR PERIOD (1988-2011)
NEW THERAPEUTIC STRATEGIES HAVE CHANGED THE NATURAL HISTORY OF PAEDIATRIC INFLAMMATORY BOWEL DISEASES: RESULTS FROM A POPULATION-BASED COHORT OVER A 24-YEAR PERIOD (1988-2011)

Mathurin Fumery  et al.

CANCER INCIDENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND A PRIOR NON-DIGESTIVE MALIGNANCY ACCORDING TO THE IMMUNOMODULATORY THERAPY: A MULTICENTER COHORT STUDY
CANCER INCIDENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND A PRIOR NON-DIGESTIVE MALIGNANCY ACCORDING TO THE IMMUNOMODULATORY THERAPY: A MULTICENTER COHORT STUDY

Mathurin Fumery  et al.

IMPACT OF ABDOMINOPELVIC RADIOTHERAPY ON INFLAMMATORY BOWEL DISEASE ACTIVITY: A MULTICENTER COHORT STUDY FROM THE GETAID
IMPACT OF ABDOMINOPELVIC RADIOTHERAPY ON INFLAMMATORY BOWEL DISEASE ACTIVITY: A MULTICENTER COHORT STUDY FROM THE GETAID

Mathurin Fumery  et al.

COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS

Mathurin Fumery  et al.

Item 1 - 15 / 15
1